Qiagen NV - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
QGEN New York 2836 https://www.qiagen.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Qiagen NV

Here is What Hedge Funds Think About Qiagen NV (QGEN) - Apr 18th, 2019 5:47 pm
QIAGEN Drives Molecular Diagnostics Suite With New Test Kit - Apr 16th, 2019 8:54 am
QIAGEN N.V. to Report First Quarter 2019 Results - Apr 15th, 2019 4:54 am
QIAGEN Launches First FDA-Approved Companion Diagnostic Using FGFR Alterations to Help Guide the Treatment of Metastatic Urothelial Cancer - Apr 12th, 2019 1:23 pm
QIAGEN’s QuantiFERON®-TB Passes Milestone of 60 Million Tests in Global Fight against Tuberculosis, Current Annual Run Rate Exceeds 12 Million Tests - Apr 11th, 2019 2:02 pm
QIAGEN and NeuMoDx expand assay menu for their next generation of fully integrated PCR systems for clinical laboratories in Europe and also announce availability of NeuMoDx 96 version - Apr 11th, 2019 2:01 pm
QIAGEN Highlights Profile of New QIAstat-Dx Meningitis / Encephalitis pAnel Focused on Most Prevalent Central Nervous System Pathogens - Apr 11th, 2019 2:00 pm
See what the IHS Markit Score report has to say about Qiagen NV. - Apr 9th, 2019 8:50 am
LabCorp (LH)-QIAGEN Form Alliance in In-Vitro Diagnostics - Apr 4th, 2019 8:48 am
QIAGEN and LabCorp Launch Collaboration to Provide Day-One Access for Patients to Innovative Companion Diagnostics at the Time of Drug Approvals - Apr 3rd, 2019 2:00 pm
QIAGEN Launches Novel Liquid Biopsy Solutions and NGS Panels with Seamlessly Integrated Bioinformatics to Support Advances in Cancer Research - Mar 28th, 2019 3:00 pm
QIAGEN supports World TB Day with major innovations in the fight against latent tuberculosis - Mar 24th, 2019 1:00 am
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? - Mar 20th, 2019 5:07 am
Is QIAGEN N.V.’s (NYSE:QGEN) Balance Sheet A Threat To Its Future? - Mar 17th, 2019 7:53 am
Natera Inc (NTRA) Q4 2018 Earnings Conference Call Transcript - Mar 12th, 2019 6:31 pm
QIAGEN Partners With Tecan to Advance QFT-Plus Diagnostic Test - Mar 12th, 2019 7:02 am
QIAGEN and Tecan Announce Collaboration to Streamline Preanalytical Processing of QuantiFERON-TB Gold Plus - Mar 7th, 2019 11:00 pm
Why Is Qiagen (QGEN) Up 8.1% Since Last Earnings Report? - Mar 6th, 2019 7:30 am